Technology
Health
Medical

Chembio

$6.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.12 (-1.69%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Chembio and other stocks, options, ETFs, and crypto commission-free!

About

Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. Its products include human and veterinary diagnostics. Read More The company was founded in 1985 and is headquartered in Medford, NY.

Employees
295
Headquarters
Medford, New York
Founded
1985
Market Cap
121.71M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
61.42K
High Today
$7.23
Low Today
$6.88
Open Price
$7.23
Volume
9.47K
52 Week High
$11.55
52 Week Low
$4.85

Collections

Technology
Health
Medical
US
North America

News

Yahoo FinanceMay 7

Chembio Diagnostics Announces Approval of Dengue Point-of-Care Test by Brazil’s Health Regulatory Agency

MEDFORD, N.Y., May 07, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the approval of its DPP Dengue System by Agência Nacional de Vigilância Sanitária (ANVISA), Brazil’s health regulatory agency, in collaboration with Bio-Manguinhos, a Brazilian government agency and supplier of diagnostic products to Brazil’s Ministry of Health. Chembio’s DPP Dengue test allows simultaneous and discrete detection of ...

14
Yahoo FinanceMay 2

Edited Transcript of CEMI earnings conference call or presentation 1-May-19 8:30pm GMT

Q1 2019 Chembio Diagnostics Inc Earnings Call MEDFORD May 2, 2019 (Thomson StreetEvents) -- Edited Transcript of Chembio Diagnostics Inc earnings conference call or presentation Wednesday, May 1, 2019 at 8:30:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * John J. Sperzel Chembio Diagnostics, Inc. - President, CEO & Director * ...

4
Yahoo FinanceMay 1

Chembio Diagnostics Reports First Quarter 2019 Financial Results

MEDFORD, N.Y., May 01, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter ended March 31, 2019. Recent Accomplishments & Highlights Achieved total revenue of $8.3 million for the first quarter of 2019, growth of 8% compared to the prior year period Commenced production of DPP tests on fully automated manufacturing line Received ANVISA approval in Brazil for DPP Zika/Deng...

5

Earnings

-$0.21
-$0.16
-$0.10
-$0.05
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.